Related references
Note: Only part of the references are listed.Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction
Ashish Rastogi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Traditional Chinese Medicine on the Treatment of Coronary Heart Disease in Recent 20 Years
Ping Gong et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2017)
Cardioprotective effect of nesfatin-1 against isoproterenol-induced myocardial infarction in rats: Role of the Akt/GSK-3β pathway
Arda Tasatargil et al.
PEPTIDES (2017)
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Kelly L. Walton et al.
FRONTIERS IN PHARMACOLOGY (2017)
The JNK Signaling Pathway in Renal Fibrosis
Keren Grynberg et al.
FRONTIERS IN PHYSIOLOGY (2017)
Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways
Xin Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration
Virpi Talman et al.
CELL AND TISSUE RESEARCH (2016)
Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure
Feifei Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
The Biological Basis for Cardiac Repair After Myocardial Infarction From Inflammation to Fibrosis
Sumanth D. Prabhu et al.
CIRCULATION RESEARCH (2016)
Ginsenoside Rg3 Improves Cardiac Function after Myocardial Ischemia/Reperfusion via Attenuating Apoptosis and Inflammation
Li-ping Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
L-Arginine Attenuates Cardiac Dysfunction, But Further Down-Regulates α-Myosin Heavy Chain Expression in Isoproterenol-Induced Cardiomyopathy
Eva Kralova et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling
Federica Accornero et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats
Wei Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases
Chang Ho Lee et al.
JOURNAL OF GINSENG RESEARCH (2014)
Merit of Ginseng in the Treatment of Heart Failure in Type 1-Like Diabetic Rats
Cheng-Chia Tsai et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Roles and Mechanisms of Ginseng in Protecting Heart
Zheng Si-dao et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2012)
Ginseng Reverses Established Cardiomyocyte Hypertrophy and Postmyocardial Infarction-Induced Hypertrophy and Heart Failure
Melissa Moey et al.
CIRCULATION-HEART FAILURE (2012)
Effect of ginsenoside Rh1 on myocardial injury and heart function in isoproterenol-induced cardiotoxicity in rats
Yusheng Gai et al.
TOXICOLOGY MECHANISMS AND METHODS (2012)
Fasudil Hydrochloride Hydrate, a Rho-Kinase Inhibitor, Suppresses Isoproterenol-Induced Heart Failure in Rats via JNK and ERK1/2 Pathways
Na Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method
Kyung-Mi Joo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Molecular determinants of heart failure with normal left ventricular ejection fraction
Attila Borbely et al.
PHARMACOLOGICAL REPORTS (2009)
Ginsenoside re reduces insulin resistance through inhibition of c-jun NH2-terminal kinase and nuclear factor-kappa B
Zhiguo Zhang et al.
MOLECULAR ENDOCRINOLOGY (2008)
Ginsenoside, Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats
William C. S. Cho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)